EC
CYTK icon

EcoR1 Capital’s Cytokinetics CYTK Stock Holding History

EcoR1 Capital’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-54,879
Closed -$667K – 35
2016
Q4 		$667K Sell
54,879
-791,775
-94% -$8.4M 0.21% 28
2016
Q3 		$7.77M Sell
846,654
-1,293,043
-60% -$13.5M 2.38% 16
2016
Q2 		$20.3M Buy
2,139,697
+86,897
+4% +$713K 8.01% 4
2016
Q1 		$14.5M Buy
2,052,800
+634,100
+45% +$4.63M 5.06% 8
2015
Q4 		$14.8M Buy
+1,418,700
New +$13.9M 4.66% 8

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $2.43B AUM 103.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

EcoR1 Capital's CYTK Position: Q1 2017 in Review

EcoR1 Capital sold out of Cytokinetics (CYTK) in Q1 2017, closing a stake of 54,879 shares — an estimated $667K sold.

EcoR1 Capital first reported a position in CYTK in Q4 2015 and held it in 5 quarters. The position peaked at $20.3M in Q2 2016. 108 funds tracked by Wall St. Rank hold CYTK as of Q1 2017.

  • EcoR1 Capital reported no remaining Cytokinetics position as of Q1 2017 after selling out during the quarter.
  • EcoR1 Capital sold 54,879 Cytokinetics shares in Q1 2017, an estimated $667K.
  • EcoR1 Capital first reported a position in Cytokinetics in Q4 2015 and held it in 5 quarters.
  • EcoR1 Capital's Cytokinetics position peaked at $20.3M in Q2 2016.
  • 108 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2017.

Based on EcoR1 Capital's 13F filing for Q1 2017, filed 15 May 2017.